Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Stride (LRN) Gains from Investment Securities (2016 - 2025)

Stride (LRN) has disclosed Gains from Investment Securities for 16 consecutive years, with $14.0 million as the latest value for Q4 2025.

  • On a quarterly basis, Gains from Investment Securities rose 75.45% to $14.0 million in Q4 2025 year-over-year; TTM through Dec 2025 was $42.7 million, a 49.15% increase, with the full-year FY2025 number at -$1.7 million, down 590.27% from a year prior.
  • Gains from Investment Securities was $14.0 million for Q4 2025 at Stride, up from $12.0 million in the prior quarter.
  • In the past five years, Gains from Investment Securities ranged from a high of $30.5 million in Q1 2023 to a low of -$20.0 million in Q2 2022.
  • A 5-year average of $4.6 million and a median of $4.2 million in 2024 define the central range for Gains from Investment Securities.
  • Peak YoY movement for Gains from Investment Securities: crashed 98.22% in 2023, then surged 60875.05% in 2024.
  • Stride's Gains from Investment Securities stood at $38575.0 in 2021, then decreased by 1.79% to $37886.0 in 2022, then plummeted by 65.51% to $13066.0 in 2023, then soared by 60875.05% to $8.0 million in 2024, then surged by 75.45% to $14.0 million in 2025.
  • Per Business Quant, the three most recent readings for LRN's Gains from Investment Securities are $14.0 million (Q4 2025), $12.0 million (Q3 2025), and $8.0 million (Q4 2024).